Order Article Reprints

Pandya PH, Cheng L, Saadatzadeh MR, Bijangi-Vishehsaraei K, Tang S, Sinn AL, Trowbridge MA, Coy KL, Bailey BJ, Young CN, et al. Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma. Cancers. 2020; 12(9):2426. https://doi.org/10.3390/cancers12092426

Pandya, Pankita H., Lijun Cheng, M. Reza Saadatzadeh, Khadijeh Bijangi-Vishehsaraei, Shan Tang, Anthony L. Sinn, Melissa A. Trowbridge, Kathryn L. Coy, Barbara J. Bailey, Courtney N. Young, and et al. 2020. "Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma" Cancers 12, no. 9: 2426. https://doi.org/10.3390/cancers12092426

Pandya, P. H., Cheng, L., Saadatzadeh, M. R., Bijangi-Vishehsaraei, K., Tang, S., Sinn, A. L., Trowbridge, M. A., Coy, K. L., Bailey, B. J., Young, C. N., Ding, J., Dobrota, E. A., Dyer, S., Elmi, A., Thompson, Q., Barghi, F., Shultz, J., Albright, E. A., Shannon, H. E., ... Pollok, K. E. (2020). Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma. Cancers, 12(9), 2426. https://doi.org/10.3390/cancers12092426